T. Chitnis Et Al. , "Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension," EUROPEAN JOURNAL OF NEUROLOGY , vol.29, pp.65, 2022
Chitnis, T. Et Al. 2022. Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension. EUROPEAN JOURNAL OF NEUROLOGY , vol.29 , 65.
Chitnis, T., Banwell, B., Kappos, L., Arnold, D., Gucuyener, K., Deiva, K., ... Saubadu, S.(2022). Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension. EUROPEAN JOURNAL OF NEUROLOGY , vol.29, 65.
Chitnis, T. Et Al. "Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension," EUROPEAN JOURNAL OF NEUROLOGY , vol.29, 65, 2022
Chitnis, T. Et Al. "Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension." EUROPEAN JOURNAL OF NEUROLOGY , vol.29, pp.65, 2022
Chitnis, T. Et Al. (2022) . "Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension." EUROPEAN JOURNAL OF NEUROLOGY , vol.29, p.65.
@article{article, author={T. Chitnis Et Al. }, title={Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension}, journal={EUROPEAN JOURNAL OF NEUROLOGY}, year=2022, pages={65} }